Showing results (41-50 of 176) with videos related to
Sort By:
Pageof 18
International Journal of Technology Assessment in Health Care|August 31, 2023
Cost-effectiveness of adding ezetimibe and/or PCSK9 inhibitors to high-dose statins for secondary prevention of cardiovascular disease in Chinese adultsYuliang Xiang, Lei Gan, Heyue Du, et al.Journal of Evidence-Based Medicine|September 25, 2023
Chinese guidelines for the rehabilitation treatment of knee osteoarthritis: An CSPMR evidence-based practice guidelineSiyi Zhu, Zhuo Wang, Qiu Liang, et al.Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|January 25, 2018
Berberine Modulates Gut Microbiota and Reduces Insulin Resistance via the TLR4 Signaling PathwayDan Liu, Yiyi Zhang, Yunhui Liu, et al.Frontiers in Endocrinology|September 6, 2021
Sodium-Glucose Co-Transporter-2 Inhibitors in Non-Diabetic Adults With Overweight or Obesity: A Systematic Review and Meta-AnalysisHanrui Zheng, Min Liu, Sheyu Li, et al.Frontiers in Endocrinology|March 5, 2021
Comparison of the Efficacy of Glucagon-Like Peptide-1 Receptor Agonists in Patients With Metabolic Associated Fatty Liver Disease: Updated Systematic Review and Meta-AnalysisYuzhao Dai, He He, Sheyu Li, et al.Scientific Reports|June 8, 2017
Effects of SGLT2 inhibitors on UTIs and genital infections in type 2 diabetes mellitus: a systematic review and meta-analysisJiali Liu, Ling Li, Sheyu Li, et al.Obesity Surgery|October 31, 2014
The long-term effects of bariatric surgery for type 2 diabetes: systematic review and meta-analysis of randomized and non-randomized evidenceJiajie Yu, Xu Zhou, Ling Li, et al.Drug Design, Development and Therapy|February 6, 2020
Cost-Effectiveness Analysis of Ezetimibe as the Add-on Treatment to Moderate-Dose Rosuvastatin versus High-Dose Rosuvastatin in the Secondary Prevention of Cardiovascular Diseases in China: A Markov Model AnalysisHan Yang, Nan Li, Youlian Zhou, et al.Nutrients|December 13, 2016
Metformin Treatment and Homocysteine: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsQianying Zhang, Sheyu Li, Ling Li, et al.Chinese Medical Journal|March 25, 2024
Mitochondrial energy metabolism in diabetic cardiomyopathy: Physiological adaption, pathogenesis, and therapeutic targetsWanlin Ye, Kun Han, Maodi Xie, et al.Pageof 18